MGMT and glioblastoma: Thus, Hegi et al. [25] concluded that there is no clear relationship between patients with methylated MGMT promoter and a favorable response to TMZ treatment, and Yin et al. [26] determined the predictive but not prognostic value of MGMT promoter methylation status in elderly GBM patients after TMZ treatment.